Log in

Walgreens Boots Alliance Stock Forecast, Price & News

+0.55 (+1.43 %)
(As of 11/25/2020 12:00 AM ET)
Today's Range
Now: $39.07
50-Day Range
MA: $37.70
52-Week Range
Now: $39.07
Volume6.63 million shs
Average Volume7.19 million shs
Market Capitalization$33.83 billion
P/E Ratio78.14
Dividend Yield4.85%
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides specialty pharmacy services and mail services. As of August 31, 2020, this segment operated 9,021 retail stores under the Walgreens and Duane Reade brands in the United States; and six specialty pharmacies. The Retail Pharmacy International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 550 optical practices, including 165 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More
Walgreens Boots Alliance logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.7Dividend Strength: 5.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.34 out of 5 stars

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
Current SymbolNASDAQ:WBA



Sales & Book Value

Annual Sales$139.54 billion
Cash Flow$7.44 per share
Book Value$24.41 per share


Net Income$456 million


Market Cap$33.83 billion
Next Earnings Date1/13/2021 (Estimated)
+0.55 (+1.43 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WBA News and Ratings via Email

Sign-up to receive the latest news and ratings for WBA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions

How has Walgreens Boots Alliance's stock price been impacted by COVID-19?

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WBA stock has decreased by 15.2% and is now trading at $39.07.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Walgreens Boots Alliance?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 2 sell ratings and 13 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Walgreens Boots Alliance

What stocks does MarketBeat like better than Walgreens Boots Alliance?

Wall Street analysts have given Walgreens Boots Alliance a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Walgreens Boots Alliance wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Walgreens Boots Alliance's next earnings date?

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Wednesday, January 13th 2021.
View our earnings forecast for Walgreens Boots Alliance

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) released its quarterly earnings results on Thursday, October, 15th. The pharmacy operator reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.06. The pharmacy operator earned $34.75 billion during the quarter, compared to the consensus estimate of $34.36 billion. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. The business's revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.43 earnings per share.
View Walgreens Boots Alliance's earnings history

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance declared a quarterly dividend on Friday, October 30th. Shareholders of record on Thursday, November 19th will be paid a dividend of $0.4675 per share on Friday, December 11th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 4.79%. The ex-dividend date of this dividend is Wednesday, November 18th.
View Walgreens Boots Alliance's dividend history

What price target have analysts set for WBA?

15 analysts have issued 1 year price objectives for Walgreens Boots Alliance's stock. Their forecasts range from $33.00 to $61.00. On average, they expect Walgreens Boots Alliance's stock price to reach $42.43 in the next year. This suggests a possible upside of 8.6% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance

Who are some of Walgreens Boots Alliance's key competitors?

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), The Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the following people:
  • Mr. James A. Skinner, Exec. Chairman (Age 75)
  • Mr. Stefano Pessina, Exec. Vice Chairman & CEO (Age 79, Pay $28.82k)
  • Mr. James Kehoe, Exec. VP & Global CFO (Age 58, Pay $2.24M)
  • Mr. Alexander W. Gourlay, Co-Chief Operating Officer (Age 60, Pay $1.63M)
  • Ms. Ornella Barra, Co-Chief Operating Officer (Age 67, Pay $1.42M)
  • Ms. Heather Dixon, Sr. VP, Global Controller & Chief Accounting Officer (Age 48)
  • Mr. Francesco Tinto, Global Chief Information Officer & Sr. VP
  • Mr. Marco Patrick Anthony Pagni, Exec. VP, Global Chief Admin. Officer & Gen. Counsel (Age 58)
  • Mr. Gerald Gradwell, Sr. VP of Investor Relations
  • Mr. Aaron C. Radelet, Global Chief Communications Officer & Sr. VP

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a number of retail and institutional investors. Top institutional shareholders include State Street Corp (5.36%), Caisse DE Depot ET Placement DU Quebec (1.86%), LSV Asset Management (1.06%), Morgan Stanley (0.86%), Thornburg Investment Management Inc. (0.68%) and UBS Asset Management Americas Inc. (0.51%). Company insiders that own Walgreens Boots Alliance stock include Marco Patrick Anthony Pagni and Ornella Barra.
View institutional ownership trends for Walgreens Boots Alliance

Which institutional investors are selling Walgreens Boots Alliance stock?

WBA stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Allianz Asset Management GmbH, Arrowstreet Capital Limited Partnership, First Trust Advisors LP, Nuveen Asset Management LLC, Manitou Investment Management Ltd., LSV Asset Management, and O Shaughnessy Asset Management LLC.
View insider buying and selling activity for Walgreens Boots Alliance

Which institutional investors are buying Walgreens Boots Alliance stock?

WBA stock was acquired by a variety of institutional investors in the last quarter, including Prudential PLC, Equity Investment Corp, State Street Corp, Morgan Stanley, ProShare Advisors LLC, Alps Advisors Inc., KBC Group NV, and Kiltearn Partners LLP.
View insider buying and selling activity for Walgreens Boots Alliance

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $39.07.

How big of a company is Walgreens Boots Alliance?

Walgreens Boots Alliance has a market capitalization of $33.83 billion and generates $139.54 billion in revenue each year. The pharmacy operator earns $456 million in net income (profit) each year or $4.74 on an earnings per share basis. Walgreens Boots Alliance employs 223,000 workers across the globe.

What is Walgreens Boots Alliance's official website?

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.